Filters

Jordi Costa I Colomer, Ruth Garcia Romero, Carmen Luna Paredes, Maria Dolores Pastor-Vivero, Carlos Martín de Vicente, Saioa Vicente-Santamaria, David González Jiménez

Anales de pediatria 2025;102(5):503857

Free Full Text

Abstract

New Options in Constipation Management.

Mellar Davis, Pamela Gamier

Current oncology reports 2016;17(12):55

Full Text

Abstract

Evolution of body image across treatment eras: a systematic review in young people and adults living with cystic fibrosis.

Cian Greaney, Natalia Cichy, Grace O'Sullivan, Darren Sills, Roisin Cahalan, Audrey Tierney

European respiratory review : an official journal of the European Respiratory Society 2026;35(180):

Free Full Text

Abstract

Clinical effects of the three CFTR potentiator treatments curcumin, genistein and ivacaftor in patients with the CFTR-S1251N gating mutation.

Gitte Berkers, Hettie M Janssens, Jolt Roukema, Gerard H Koppelman, Christof J Majoor, Harry Gm Heijerman, Sylvia Wf Suen, Evelien Kruisselbrink, Annelotte M Vonk, Peter van Mourik, Renske van der Meer, E Marleen Kemper, Yolanda B de Rijke, Hugo R de Jonge, Cornelis K van der Ent, Jeffrey M Beekman

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society 2021;19(6):955-961

Free Full Text

Abstract

Safety and efficacy of vanzacaftor-tezacaftor-deutivacaftor in adults with cystic fibrosis: randomised, double-blind, controlled, phase 2 trials.

Ahmet Z Uluer, Gordon MacGregor, Pilar Azevedo, Veronica Indihar, Claire Keating, Marcus A Mall, Edward F McKone, Bonnie W Ramsey, Steven M Rowe, Ronald C Rubenstein, Jennifer L Taylor-Cousar, Elizabeth Tullis, Lael M Yonker, Chenghao Chu, Anna P Lam, Nitin Nair, Patrick R Sosnay, Simon Tian, Fredrick Van Goor, Lakshmi Viswanathan, David Waltz, Linda T Wang, Yingmei Xi, Joanne Billings, Alexander Horsley

The Lancet. Respiratory medicine 2023;11(6):550-562

Free Full Text

Abstract

Impact of highly effective modulator therapy on gastrointestinal symptoms and features in people with cystic fibrosis.

Chee Y Ooi, Vito Terlizzi, Luca Scarallo, Paolo Lionetti, Martina Cecchetti

Paediatric respiratory reviews 2025;54():70-75

Full Text

Abstract

Results: 1 – 15 / 77

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Chloride Channel Agonists""[mesh_terms]

Emerging Concepts and Therapies for Mucoobstructive Lung Disease.

Challenged Urine Bicarbonate Excretion as a Measure of Cystic Fibrosis Transmembrane Conductance Regulator Function in Cystic Fibrosis.

Chronic rhinosinusitis in the era of CFTR modulator therapy.

Impact of lubiprostone on gastric-emptying profile and the possible effect of concomitant domperidone in healthy adults .

Advances in the restoration of CFTR in children and pwCF with "mild disease".

Ion transporting proteins of human bronchial epithelium.

Drug-drug interactions involving CFTR modulators: a review of the evidence and clinical implications.

The New Landscape of Cystic Fibrosis in the Era of Highly Effective Cystic Fibrosis Transmembrane Conductance Regulator Modulator Therapy.

VOCAL: An observational study of ivacaftor for people with cystic fibrosis and selected non-G551D-CFTR gating mutations.

Advances in the treatment of cystic fibrosis: CFTR modulators.

New Options in Constipation Management.

Evolution of body image across treatment eras: a systematic review in young people and adults living with cystic fibrosis.

Clinical effects of the three CFTR potentiator treatments curcumin, genistein and ivacaftor in patients with the CFTR-S1251N gating mutation.

Safety and efficacy of vanzacaftor-tezacaftor-deutivacaftor in adults with cystic fibrosis: randomised, double-blind, controlled, phase 2 trials.

Impact of highly effective modulator therapy on gastrointestinal symptoms and features in people with cystic fibrosis.

Results for
""Chloride Channel Agonists""[mesh_terms]

Impact of lubiprostone on gastric-emptying profile and the possible effect of concomitant domperidone in healthy adults .